After a long and bumpy path to approval, the U.S. FDA has finally given the green light to Cyclopharm Ltd.'s Technegas combination product a day after the Sept. 29 PDUFA date. Technegas is a nuclear ...
A discrepancy between the predicted ventilation standards and the actual ventilation requirements may be caused by an increase in the physiologic dead space or by an increased carbon dioxide ...
In a retrospective study of 100 patients treated with prolonged mechanical ventilation, water retention without evidence of cardiac failure developed in 19. This was associated with radiologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results